Deep Dive on Neuralink: Controlling Computers With Your Mind
Chamath Palihapitiya
· Chamath Palihapitiya
· February 13, 2026 at 17:42
· ⏱ 5 min read
| Read on Substack ↗
Summary
=== SUMMARY ===
•Neuralink is demonstrating significant technological de-risking and accelerating progress, with 21 human participants in clinical trials as of early 2026, validating the therapeutic use case for Brain-Computer Interfaces (BCIs).
•The company's ambitious scaling targets (10,000 implants/year by 2030) and expansive future roadmap (vision, speech, sensation) signal the creation of a new, multi-billion dollar market, which will have cascading effects on adjacent and incumbent industries.
Summary
The article provides a detailed, educational overview of Neuralink's brain-computer interface technology, its progress from animal trials to 21 human participants, and its ambitious target of 10,000 implants per year by 2030. It does not offer any investment advice or disclose personal positions, so there are no actionable trade ideas for public markets.
•The human brain receives ~1,000,000,000 bits per second but can only act on ~10 bits per second, creating a bandwidth bottleneck.
•Neuralink was founded in 2016 and performed its first human implantation of the N1 chip in Noland Arbaugh in January 2024.
•The N1 chip uses 1,024 electrodes across 64 flexible threads implanted into the motor cortex to detect neural signals.
•As of late January 2026, Neuralink has enrolled 21 participants in worldwide clinical trials, using the implant an average of 50 hours per week.
•Neuralink's target is 10,000 implants per year by 2030 at an estimated cost of $40,000–$50,000 per patient.
•Future planned capabilities include restoring tactile sensation, enabling natural speech, and restoring vision via a product called Blindsight.